MRC Technology in licensing deal with Genentech

Monday 12 July 2010

The technology transfer arm of the UK Medical Research Council has entered into an exclusive licensing agreement with Genentech Inc for access to a series of small molecule drug candidates for neurological disease. Financial terms were not given.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom